Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 349 | 1,775 | 727 | 1,444 | 7,426 |
| Marketable Securities | 125 | 486 | 1,860 | 8,332 | 12,700 |
| Receivables | 4,488 | 77 | 1,149 | 1,273 | 193 |
| Inventories | N/A | N/A | 185 | 461 | N/A |
| TOTAL | $5,159 | $3,160 | $4,819 | $12,362 | $20,930 |
| Non-Current Assets | |||||
| PPE Net | 300 | 464 | 1,004 | 742 | 477 |
| Intangibles | 1,121 | 3,207 | 4,887 | 5,308 | 2,642 |
| Other Non-Current Assets | 633 | 4,259 | 1,101 | 1,075 | 1,438 |
| TOTAL | $2,054 | $7,930 | $6,992 | $7,125 | $4,557 |
| Total Assets | $7,213 | $11,090 | $11,811 | $19,487 | $25,487 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 106 | 8,341 | 338 | 789 | 107 |
| Accounts payable and accrued liabilities | 2,883 | 1,728 | 1,780 | 2,469 | 1,486 |
| Accrued Expenses | 652 | 311 | 311 | 311 | 310 |
| TOTAL | $3,814 | $10,553 | $3,613 | $4,768 | $2,411 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,636 | 5,603 | 282 | 354 | 468 |
| Deferred Revenues | 173 | 173 | 1,184 | 1,199 | 508 |
| Other Non-Current Liabilities | 0 | 1,595 | 13,741 | 13,876 | 13,530 |
| TOTAL | $7,636 | $7,198 | $14,023 | $14,230 | $13,998 |
| Total Liabilities | $11,450 | $17,751 | $17,636 | $18,998 | $16,409 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 2 | 2 | 2 | 2 |
| Common Shares | 35 | 155 | 134 | 132 | 132 |
| Retained earnings | -66,165 | -64,465 | -54,227 | -47,292 | -37,908 |
| Other shareholders' equity | -1,049 | -1,361 | -1,329 | -1,340 | -1,203 |
| TOTAL | $-4,237 | $-6,661 | $-5,825 | $489 | $9,078 |
| Total Liabilities And Equity | $7,213 | $11,090 | $11,811 | $19,487 | $25,487 |